Profiel
Esben Nørgaard Flindt was the founder of Unest A, founded in 2003, where he held the title of Chief Scientific Officer, and Ubeamion ApS, founded in 2001, where he held the title of Chief Executive Officer from 2009 to 2012.
Currently, he is the Chief Executive Officer & Director at BioLigands ApS since 2005.
Dr. Flindt's former job was as a Manager at Genetic Signatures Ltd. from 2004 to 2005.
He received his doctorate degree from the University of Southern Denmark in 2004.
Actieve functies van Esben Nørgaard Flindt
| Bedrijven | Functie | Begin |
|---|---|---|
BioLigands ApS
BioLigands ApS BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Algemeen Directeur | 22-10-2009 |
Eerdere bekende functies van Esben Nørgaard Flindt
| Bedrijven | Functie | Einde |
|---|---|---|
| GENETIC SIGNATURES LIMITED | Corporate Officer/Principal | 01-01-2005 |
Unest A/S
Unest A/S Medical/Nursing ServicesHealth Services Researches in the biotechnology industry | Oprichter | - |
Ubeamion ApS | Oprichter | - |
Opleiding van Esben Nørgaard Flindt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Genetic Signatures Ltd.
Genetic Signatures Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes diagnostic kits | Commercial Services |
Unest A/S
Unest A/S Medical/Nursing ServicesHealth Services Researches in the biotechnology industry | Health Services |
University of Southern Denmark
University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLigands ApS
BioLigands ApS BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Ubeamion ApS |
















